Vienna—A novel risk assessment tool for patients with colorectal cancer and ulcerative colitis and low-grade dysplasia (LGD) is now available online. The tool makes the prediction using just seven variables and is intended to help patients consider their options for risk modification, its creators reported.
The risk assessment tool “provides the user with the patient’s predicted cumulative risk of high-grade dysplasia and colorectal cancer, both quantitatively and in terms of